Product/Composition:- | Diptheria Pertussis Tetanus (dpt)vaccine |
---|---|
Strength:- | Diph. toxoid: ≥ 30 International Units ; Tetanus toxoid: ≥ 40 International Units |
Form:- | Injection |
Reference Brands:- | Daptacel®, Infanrix®(US); Boostrix® ,Tripedia® (EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
DPT vaccine injection typically contains ≥30 IU diphtheria toxoid, ≥40 IU tetanus toxoid, and either whole-cell or acellular pertussis antigens per 0.5 mL dose. This combination ensures effective protection against diphtheria, pertussis, and tetanus in infants and children.
The Diphtheria, Pertussis, Tetanus (DPT) vaccine injection is a combined immunization product providing protection against three serious bacterial diseases. It contains standardized doses of diphtheria toxoid (≥30 IU), tetanus toxoid (≥40 IU), and whole-cell or acellular pertussis antigens per 0.5 mL dose. Administered intramuscularly, it is essential in pediatric vaccination schedules to prevent diphtheria, whooping cough, and tetanus. Manufactured under stringent EU-GMP and USFDA standards, the DPT vaccine is widely supplied for hospital tenders, public health programs, and B2B distribution in the EU and US markets, supporting immunization coverage worldwide.